Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises
In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (CDMO). However, underneath all those metrics, a single truth remains: if quality fails, so does everything else. read more
Future-Proofing Pharmacovigilance in an AI Era
Clinical research organizations (CROs) are entering an era in which pharmacovigilance systems are doing more than just tracking copious amounts of data. They must also keep pace with evolving regulations, manage the growing volume of adverse event reports, and respond to heightened scrutiny from both regulators and the public. read more
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to 2030
The global pharmaceutical sterile and prefilled syringe market has experienced remarkable growth in recent years, fueled by technological advances and evolving therapeutic needs. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Frontage Laboratories Completes Acquisition of Teddy Lab
Thursday, March 05, 2026
Frontage Laboratories announced the completion of the acquisition of Teddy Clinical Research Laboratory, a clinical research laboratory service ... read more
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
Thursday, March 05, 2026
Quotient Sciences announced an extended commercial supply partnership with Ipsen, a global biopharmaceutical company, to manufacture a treatment for ... read more
Codis Expands Commercial-Scale Amorphous Solid Dispersions Manufacturing
Wednesday, March 04, 2026
Codis announced a major expansion of its UK manufacturing capabilities with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. ... read more
Forma Life Sciences Launches U.S. Based CDMO
Wednesday, March 04, 2026
Forma Life Sciences announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral ... read more
Ardena Appoints Paul Edwards as Chief People Officer
Tuesday, March 03, 2026
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational ... read more